Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray

Author:

Camerini David12,Randall Arlo Z.1,Trappl-Kimmons Krista1,Oberai Amit1,Hung Christopher1,Edgar Joshua1,Shandling Adam1,Huynh Vu1,Teng Andy A.1,Hermanson Gary1,Pablo Jozelyn V.1,Stumpf Megan M.3,Lester Sandra N.3,Harcourt Jennifer3,Tamin Azaibi3,Rasheed Mohammed3,Thornburg Natalie J.3,Satheshkumar Panayampalli S.3,Liang Xiaowu1,Kennedy Richard B.4,Yee Angela1,Townsend Michael3,Campo Joseph J.1

Affiliation:

1. Antigen Discovery Incorporated (ADI), Irvine, California, USA

2. University of California, Irvine, California, USA

3. Centers for Disease Control and Prevention, Atlanta, Georgia, USA

4. Mayo Clinic, Rochester, Minnesota, USA

Abstract

With novel mutant SARS-CoV-2 variants of concern on the rise, knowledge of immune specificities against SARS-CoV-2 proteins is increasingly important for understanding the impact of structural changes in antibody-reactive protein epitopes on naturally acquired and vaccine-induced immunity, as well as broader topics of cross-reactivity and viral evolution. A multi-coronavirus protein microarray used to map the binding of COVID-19 patient antibodies to SARS-CoV-2 proteins and protein fragments as well as to the proteins of four other coronaviruses that infect humans has shown specific regions of SARS-CoV-2 proteins that are highly reactive with patient antibodies and revealed cross-reactivity of these antibodies with other human coronaviruses.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Reference42 articles.

1. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

2. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

3. Estimates of the severity of coronavirus disease 2019: a model-based analysis

4. Antibody responses to SARS-CoV-2 in patients with COVID-19

5. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3